Earnings Preview For Coherus BioSciences
Portfolio Pulse from Benzinga Insights
Coherus BioSciences (NASDAQ:CHRS) is set to release its quarterly earnings report on August 2, 2023. Analysts estimate an earnings per share (EPS) of $-0.52. The company's previous quarter saw a miss in EPS by $0.18, resulting in a 27.4% drop in share price. The company's shares were trading at $4.82 as of July 31, with a 52-week period showing a 55.37% decrease.
August 04, 2023 | 10:16 am
News sentiment analysis
Sort by:
Descending
NEGATIVE IMPACT
Coherus BioSciences is expected to report an EPS of $-0.52. The company's stock price dropped 27.4% after missing EPS estimates last quarter. The stock has been on a downward trend, decreasing 55.37% over the last 52 weeks.
The company's stock price has been on a downward trend, and the previous quarter's miss on EPS estimates resulted in a significant drop in share price. If the company misses estimates again, it could further negatively impact the stock price.
CONFIDENCE 90
IMPORTANCE 80
RELEVANCE 100